Search results
OpenAI plans power deal with Altman's nuclear fusion startup
The Register· 2 hours agoOpenAI is reportedly in talks with Helion to get access to the startup's not-yet-possible nuclear ...
Waystar Holding Prices Prices 45M Share IPO at $21.50/sh - Reuters By Investing.com
Investing.com· 3 hours agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks...
OpenAI seeks ‘vast quantities’ of nuclear fusion energy to power superhuman AI
The Independent US via AOL· 1 day agoChatGPT creator OpenAI is reportedly seeking a deal with a next-generation energy firm to buy “vast...
Nuclear fusion start-up Xcimer secures $100m to advance laser tech
Power Technology via Yahoo Finance· 1 day agoAmerican nuclear fusion startup Xcimer Energy has raised $100m in a Series A funding round to bring...
US Moves to Accelerate Fusion Energy Amid Slow Progress
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- The Biden administration is stepping up its efforts to support research into fusion...
Denver energy company raises $100 million, aims to put laser fusion energy on the map - Denver...
The Business Journals· 3 hours agoA Denver energy technology startup says it has raised $100 million it plans to use to create a...
Helion Energy teams aim to harness fusion power for a clean energy future in Washington and beyond -...
The Business Journals· 4 hours agoThe senior fusion technician in this article’s feature image is fighting climate change. Welcome to...
Asian-Latino Fusion Is Timeless—These 3 NYC Restaurants Prove It
PureWow via Yahoo News· 12 hours agoGrowing up in the San Francisco Bay Area, I had a distinct notion of Asian fusion cuisine. My...
Hillary Clinton's D-Day comments spark fierce backlash: 'Sick and disgusting'
Fox News· 3 hours agoHillary Clinton's social media post commemorating the 80th anniversary of D-Day drew strong backlash...
Biomea Fusion Down 61% on Clinical Hold for Diabetes Drug
Morningstar· 3 hours agoBiomea Fusion shares fell 61% to $4.40 after hours as the company said the Food and Drug Administration placed a full clinical hold on Phase I/II clinical trials of diabetes ...